Ramathibodi中毒中心评分系统的开发与验证:预测住院中毒患者随访必要性
本研究基于Ramathibodi中毒中心9年数据(推导队列70%、内部验证30%,共105,342例)开发并验证预测住院中毒患者院内死亡的风险评分,另用2025年1年数据(5,578例)做时间验证。独立预测因子包括农药暴露(最强)、毒物不明、暴露原因不明或故意、高龄(>60岁)和男性。评分区分度良好:AUC在推导、内部和时间验证队列分别为0.828、0.831和0.753;低风险(0-5分)死亡率0.62%、NPV 99.4%,高风险(≥15分)死亡率22.22%。时间验证初期因流行病学变化低估死亡(O:E 1.528),经logistic再校准后O:E为1.000。结论:该评分可安全识别低风险患者以降级监测,但需定期本地再校准,并作为临床判断的辅助。
要点
- 低风险(评分0-5分)住院中毒患者死亡率为0.62%,阴性预测值99.4%,可安全实施按需监测、降级监护。
- 高风险(评分≥15分)患者死亡率达22.22%,应优先分配监护与救治资源。
- 独立预测因子为农药暴露(最强预测因子)、毒物不明、暴露原因不明或故意、年龄>60岁和男性。
- 评分区分度:推导队列AUC 0.828、内部验证0.831、时间验证0.753;时间验证初期O:E 1.528提示低估死亡,再校准后为1.000。
- 评分须定期本地再校准以应对毒物流行病学变化,且仅作为临床判断的辅助,不能替代临床评估。
适用人群与场景
- 住院中毒患者(Ramathibodi中毒中心9年数据推导与内部验证,及2025年1年数据时间验证);原文未提及明确的排除标准。
诊断标准与关键阈值
- Ramathibodi中毒评分:独立预测因子为农药暴露、毒物不明、暴露原因不明或故意、年龄>60岁、男性;风险分层为低风险0-5分(死亡率0.62%,NPV 99.4%)与高风险≥15分(死亡率22.22%)。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 回顾性研究,推导队列(70%)与内部验证队列(30%)共105,342例,时间验证5,578例;预测院内死亡,AUC推导0.828、内部0.831、时间0.753;推导队列O:E 1.000,时间验证初期O:E 1.528,logistic再校准后O:E 1.000;低风险0-5分死亡率0.62%、NPV 99.4%,高风险≥15分死亡率22.22%。
证据类型、等级与局限
- 回顾性研究(推导+内部验证+时间验证),单中心(Ramathibodi中毒中心)数据;原文未提及证据等级;局限包括回顾性设计、时间验证初期校准不佳(O:E 1.528)需再校准、流行病学变化影响校准。
对床旁实践的改变
- 可依据评分识别低风险(0-5分)住院中毒患者以实施按需监测、降级监护(NPV 99.4%),并对高风险(≥15分)患者优先配置资源;使用前需本地再校准,且评分仅作为临床判断的辅助,不能替代临床评估。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The Ramathibodi Poison Center manages a substantial workload of 30,000-40,000 annual inquiries, placing significant strain on limited human resources. We aim to develop and validate a practical risk assessment score (Ramathibodi Poison Score) to predict in-hospital mortality among hospitalized poisoned patients, thereby facilitating evidence-based patient prioritization and resource allocation.
METHODS: A retrospective study used a 9-year dataset partitioned into derivation cohort (70%) and internal validation cohort (30%), while a subsequent 1-year dataset (2025) served for temporal validation. Predictors were identified using multivariable logistic regression, and coefficients were transformed into a simplified integer-based score.
RESULTS: A total of 105,342 cases were included in the primary analysis, with 5,578 cases for temporal validation. Independent predictors of mortality included pesticide exposure (the strongest predictor), unknown toxic substance, undetermined or intentional exposure, advanced age (>60 years), and male sex. The score demonstrated robust discrimination with AUC values of 0.828 (derivation), 0.831 (internal), and 0.753 (temporal). Calibration yielded an observed-to-expected (O:E) ratio of 1.000 in the derivation cohort, whereas initial temporal validation demonstrated an underestimation of mortality (O:E 1.528) due to shifting epidemiology. Following logistic recalibration, the O:E ratio in the temporal cohort was 1.000. The score stratified patients from low risk (score 0-5; 0.62% mortality, negative predictive value (NPV) 99.4%) to high risk (score ≥15; 22.22% mortality).
DISCUSSION: The score addresses existing severity score limitations by stratifying risk before clinical deterioration. The robust NPV at the low-risk threshold confirms the safety of on-demand surveillance. Furthermore, initial temporal miscalibration highlights the dynamic nature of toxicology, emphasizing the need for periodic local recalibration against emerging threats.
CONCLUSION: The Ramathibodi Poison Score utilizes simple variables to predict mortality with robust discrimination. It safely identifies low-risk patients for de-escalated surveillance. With necessary periodic recalibration, it provides a dynamic, evidence-based framework for efficient resource allocation as an adjunct to clinical judgment.
参考来源
- Sanprasert K, Trakulsrichai S, Tansuwannarat P, et al. Development and validation of a Ramathibodi Poison Center scoring system to predict follow-up necessity in hospitalized patients: a retrospective study. Clin Toxicol (Phila). 2026. PMID: 42489133. doi:10.1080/15563650.2026.2691830
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。